Hims & Hers Health Q1 2024 GAAP EPS $0.05 Beats $0.02 Estimate, Sales $278.171M Beat $270.382M Estimate
Portfolio Pulse from Benzinga Newsdesk
Hims & Hers Health (HIMS) reported Q1 2024 earnings of $0.05 per share, surpassing the $0.02 estimate, with sales of $278.171M beating the $270.382M estimate, marking a 45.81% increase from the previous year.
May 06, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hims & Hers Health (HIMS) exceeded Q1 2024 earnings and sales estimates, showing significant year-over-year growth.
Beating both earnings and sales estimates significantly, especially with a 45.81% increase in sales compared to the same period last year, indicates strong financial health and operational efficiency. This performance is likely to positively influence investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100